Mohammed Alajlan

ORCID: 0009-0007-5497-0458
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Dermatology and Skin Diseases
  • Autoimmune Bullous Skin Diseases
  • Psoriasis: Treatment and Pathogenesis
  • Allergic Rhinitis and Sensitization
  • Food Allergy and Anaphylaxis Research
  • Skin and Cellular Biology Research
  • Colorectal and Anal Carcinomas
  • Genital Health and Disease
  • Hidradenitis Suppurativa and Treatments
  • Spondyloarthritis Studies and Treatments
  • Urticaria and Related Conditions
  • Dermatological and COVID-19 studies
  • Skin Diseases and Diabetes

King Fahd Medical City
2018-2024

Messenger RNA vaccines, commonly known as mRNA are the first COVID-19 vaccines that have been authorized and licensed in United States. Two BNT162b2 (Pfizer-BioNTech) mRNA-1273 (Moderna) available. Mass vaccination remains most critical way to halt spread of COVID pandemic. The common adverse effects headache, muscular soreness, weariness, redness, swelling, tenderness at injection site. dermatological on other hand, little understood. We present a case bullous fixed medication eruption...

10.1016/j.amsu.2022.103420 article EN Annals of Medicine and Surgery 2022-03-01

Atopic dermatitis (AD) is a long-term, pruritic, recurrent, systemic, inflammatory skin disorder. In the Middle East region, burden of AD understudied, and there dearth guideline documents for practitioners.An expert panel meeting, encompassing 12 dermatologists from Kingdom Saudi Arabia (KSA), was congregated to develop evidence- experience-based consensus recommendations management, especially in adults KSA. They completed questionnaire with seven clinical statements, defined when...

10.2147/ccid.s357178 article EN cc-by-nc Clinical Cosmetic and Investigational Dermatology 2022-07-01

Abstract Introduction Psoriasis (PsO) is an immune-mediated chronic inflammatory disease that results in severe outcomes impact the patient’s quality of life and work productivity. We investigated effectiveness secukinumab patients with plaque psoriasis psoriatic arthritis (PsA) over a 12-month period. Methods This was longitudinal, retrospective study medical records 81 and/or who had been treated for at least 12 weeks. Results The Area Severity Index (PASI), Body Surface (BSA) percentage,...

10.1186/s42358-024-00371-1 article EN cc-by Advances in Rheumatology 2024-04-29

Purpose: There is limited information about the diagnosis and treatment of hidradenitis suppurativa (HS) in Kingdom Saudi Arabia (KSA). This Delphi consensus study was conducted to develop recommendations for management HS KSA.Methods: The expert panel including 12 dermatologists with extensive experience treating patients provided nine statements on assessment, management, comorbidities multidisciplinary approach, education. experts also developed clinical questions pertaining rolled out as...

10.1080/09546634.2024.2353693 article EN cc-by-nc Journal of Dermatological Treatment 2024-06-11

The Koebner phenomenon (KP) was first described in patients with psoriasis.1 It subsequently reported to occur many dermatologic disorders.2 However, reverse KP, defined as the disappearance of lesions a particular dermatosis at injury site, is rare condition only few cases.3-6

10.1016/j.jdcr.2018.02.009 article EN cc-by-nc-nd JAAD Case Reports 2018-06-14
Coming Soon ...